ModelEdge

TenX Keane Acquisition
TENK
Filing Type8-K
Filing Date9/9/2025
Updated9/10/25, 2:45 PM

Filing

8-K
Earnings Release

Exhibits

8-KMaterial Contracts, Unregistered Sales of Equity Securities, Other Events
EX-4.1FORM OF COMMON WARRANT
EX-4.2FORM OF PLACEMENT AGENT WARRANT
EX-5.1OPINION OF WYRICK ROBBINS YATES & PONTON LLP
EX-10.1PLACEMENT AGENCY AGREEMENT, DATED AS OF SEPTEMBER 9, 2025, BY AND BETWEEN CITIUS ONCOLOGY, INC. AND MAXIM GROUP LLC
EX-10.2FORM OF SECURITIES PURCHASE AGREEMENT, DATED AS OF SEPTEMBER 9, 2025, BY AND BETWEEN CITIUS ONCOLOGY, INC. AND THE PURCHASER SIGNATORY THERETO
EX-10.3AMENDMENT TO PROMISSORY NOTE, DATED SEPTEMBER 10, 2025, BY AND BETWEEN CITIUS ONCOLOGY, INC. AND CITIUS PHARMACEUTICALS, INC
EX-99.1Material Contracts, Unregistered Sales of Equity Securities, Other Events
EX-99.2Material Contracts, Unregistered Sales of Equity Securities, Other Events